Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992471 · ClinicalTrials.gov registry record
Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 197
- Enrollment target
NCT01992471: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01992471 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 197 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992471 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what kinds of information people would like to receive from a new kind of genetic testing, and how they respond to this new kind of testing.
Interventions
- OTHER Blood draw
- BEHAVIORAL Pre-test Assessment
- BEHAVIORAL Pre test Counseling
- BEHAVIORAL Post-test counseling, and post-test assessment
- BEHAVIORAL Follow-up assessments (6 and 12 months)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01992471
The ClinicalTrials.gov registry entry for NCT01992471 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood draw is the first listed.
NCT01992471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01992471 about?
NCT01992471 is a clinical study titled "Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing". The purpose of this study is to find out what kinds of information people would like to receive from a new kind of genetic testing, and how they respond to this new kind of testing.
What is the current status of trial NCT01992471?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2013-11. Estimated completion is 2017-12-01.
What interventions are being tested in trial NCT01992471?
The interventions under investigation include: Blood draw (OTHER), Pre-test Assessment (BEHAVIORAL), Pre test Counseling (BEHAVIORAL), Post-test counseling, and post-test assessment (BEHAVIORAL), Follow-up assessments (6 and 12 months) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01992471?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.